Us-china Biomedical Technology, Inc. Asset Turnover Ratio (CLDS), as of first quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Us-china Biomedical Technology, Inc.  (CLDS)
    Sector • Services    Industry • Advertising
   Industry • Advertising
   Sector • Services
 

Us-china Biomedical Technology Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet May 31 2019, Us-china Biomedical Technology, Inc. has not recorded any assets.
Visit Us-china Biomedical Technology, Inc. Balance sheet

Within sector Us-china Biomedical Technology, Inc. achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the First Quarter 2020 compared to previous quarter at no. .

Asset Turnover Ratio Definition



CLDS Asset Turnover Ratio (May 31 2019)
I. Quarter
(Feb 28 2019)
IV. Quarter
(Nov 30 2018)
III. Quarter
(Aug 31 2018)
II. Quarter
(May 31 2018)
I. Quarter
Y / Y Asset Change -1.71 % -3.9 % 4674.92 % 3716.74 % 4185.19 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) - - - - -
CLDS's Total Ranking # # # # #
Seq. Asset Change 529.65 % -67.62 % -35.72 % -25 % 515.62 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Advertising Industry #
Services Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending May 31 2019, within Services Sector Asset Turnover Ratio Revenues for 12 Months ending May 31 2019 Assets at quarter ending May 31 2019



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.